
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of its QuikClot Control+™ Hemostatic …
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device Read More